Use of AHR-5850 and AHR-6293 to distinguish the effect of anti-platelet aggregating drug properties from the effect of anti-inflammatory properties on an in vivo model of platelet aggregation.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001160:Arterioles; D001577:Benzophenones / Q000494:pharmacology; D001921:Brain / Q000098:blood supply; D004305:Dose-Response Relationship, Drug; D051379:Mice; D008954:Models, Biological; D010648:Phenylacetates / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*
D000893:Anti-Inflammatory Agents; D001577:Benzophenones; D010648:Phenylacetates